Low LDL Cholesterol Test: Causes, Very Low LDL, Health Effects, and Meaning

LDL cholesterol is often called “bad cholesterol” because high levels can build up inside artery walls and raise the risk of heart attack and stroke. A low LDL cholesterol result usually means there are fewer LDL particles carrying cholesterol through the bloodstream, which is often beneficial for cardiovascular risk. Still, a very low LDL result can raise questions when it appears unexpectedly, occurs without cholesterol-lowering treatment, or comes with symptoms such as weight loss, diarrhea, liver enzyme changes, or signs of poor nutrient absorption.

A low LDL cholesterol test result is not interpreted the same way for everyone. For a person taking a statin, ezetimibe, or a PCSK9 inhibitor after a heart attack, an LDL below 55 mg/dL may be an intended treatment target. For someone not taking lipid-lowering medication, repeated LDL levels below about 50 mg/dL deserve a closer look for genetic, thyroid, liver, digestive, nutritional, or chronic disease causes.

• Low LDL cholesterol is usually defined by context; many clinicians pay closer attention when untreated LDL-C is below about 50 mg/dL.
• Very low LDL cholesterol often means LDL-C below 40 mg/dL, while extremely low results near 20 mg/dL or lower need clearer clinical context.
• Low LDL from treatment is often intentional in people with high cardiovascular risk, especially after heart attack, stroke, stent placement, or known artery disease.
• Unexpected low LDL can be caused by hyperthyroidism, malabsorption, chronic liver disease, severe illness, malnutrition, cancer, or inherited hypobetalipoproteinemia.
• Follow-up usually starts with repeating the lipid panel and reviewing medicines, diet changes, thyroid tests, liver tests, CBC, and signs of fat-soluble vitamin deficiency.
• Urgent care is not needed for a low LDL number alone, but stroke symptoms, severe weakness, jaundice, black stools, chest pain, or sudden neurologic changes need immediate attention.

Table of Contents

• What Low LDL Cholesterol Means
• How LDL Cholesterol Is Measured
• Causes of Low LDL Cholesterol
• Very Low LDL From Cholesterol-Lowering Treatment
• Health Effects and Symptoms Linked With Very Low LDL
• What to Do After a Low LDL Result
• How Low LDL Fits Into Heart Risk

What Low LDL Cholesterol Means

Low LDL cholesterol means the measured or calculated amount of cholesterol carried by low-density lipoproteins is lower than expected for that person’s age, health status, and treatment plan. LDL particles carry cholesterol from the liver to tissues. When LDL particles are too numerous over many years, they can enter artery walls and contribute to plaque. When LDL is low, the blood usually carries fewer atherogenic, or plaque-forming, lipoproteins.

There is no single universal “too low” LDL number that applies to everyone. A result that looks low on a standard lab report may be excellent for someone with established coronary artery disease, but unusual for someone who is young, untreated, losing weight unintentionally, or showing signs of liver, thyroid, or digestive disease.

A typical LDL cholesterol range is interpreted alongside total cholesterol, HDL cholesterol, triglycerides, non-HDL cholesterol, ApoB, personal history, family history, and medication use. Many routine lipid panels flag LDL-C below the lab’s reference interval, but that flag does not automatically mean harm.

For general orientation:

LDL-C level	Common interpretation	Clinical context
100–129 mg/dL	Near or above typical prevention targets for many adults	May be acceptable or too high depending on risk
70–99 mg/dL	Often considered reasonable for many lower-risk adults	Still may be too high after heart attack, stroke, or known artery disease
55–69 mg/dL	Low compared with average adults	Often intentional in higher-risk patients
40–54 mg/dL	Very low or near very low	May be appropriate with treatment; unexpected if untreated
Below 40 mg/dL	Very low	Needs context, especially if untreated, new, or paired with symptoms
Below 20–25 mg/dL	Extremely low	Often seen with intensive therapy or rare genetic conditions; should be reviewed carefully

A low LDL result is more reassuring when it is expected, stable, and caused by prescribed treatment in a person with high cardiovascular risk. It deserves more investigation when it is new, unexplained, progressively falling, or accompanied by low total cholesterol, low triglycerides, anemia, high liver enzymes, hyperthyroid symptoms, chronic diarrhea, or unexplained weight loss.

How LDL Cholesterol Is Measured

LDL cholesterol is usually part of a standard lipid panel. The panel commonly includes total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, and sometimes non-HDL cholesterol. LDL-C may be calculated from the other lipid values or measured directly by the laboratory.

Most routine LDL-C results are estimates rather than direct particle counts. The classic Friedewald calculation estimates LDL-C from total cholesterol, HDL cholesterol, and triglycerides. Newer equations may perform better when triglycerides are high or LDL is very low. Some labs use direct LDL-C testing, especially when triglycerides are high or the calculated value may be unreliable.

Why an LDL result can look falsely low

LDL-C can look lower than it truly is when the calculation does not fit the person’s triglyceride level or metabolic pattern. This is more likely when triglycerides are very high, when the sample was taken soon after a fatty meal, or when LDL-C is already very low and small calculation errors become more important.

Calculated LDL-C is often less reliable when triglycerides are above 400 mg/dL. Even at lower triglyceride levels, accuracy can vary in people with diabetes, insulin resistance, kidney disease, severe inflammation, or unusual lipoprotein patterns. In these cases, non-HDL cholesterol, ApoB, or LDL particle testing can better show the number of atherogenic particles.

ApoB is especially useful because each LDL, VLDL remnant, IDL, and Lp(a) particle usually carries one ApoB molecule. If LDL-C is low but ApoB is high, the person may still have many plaque-forming particles. That pattern can happen when LDL particles are cholesterol-poor but numerous, often in insulin resistance or high triglyceride states.

Fasting and preparation

Many lipid panels can be done without fasting, especially for routine screening. Fasting for 9–12 hours may be requested when triglycerides are high, when a previous result was unusual, when LDL-C accuracy is important, or when the clinician wants to compare results over time under similar conditions.

A low LDL result should not be interpreted from one number alone. Recent illness, major diet change, rapid weight loss, a new medication, heavy alcohol use, pregnancy or the postpartum period, and major inflammation can all shift lipid values. Repeating the test after recovery or after a stable diet and medication routine often clarifies whether the result is persistent.

Causes of Low LDL Cholesterol

Low LDL cholesterol has several broad causes: intentional treatment, genetics, reduced cholesterol production, reduced absorption of dietary fat, increased LDL clearance, or illness that changes the body’s metabolism. The cause is usually easier to identify when the clinician compares the current LDL with older lipid results.

A lifelong LDL-C of 35–55 mg/dL in a healthy person with similar family results points toward a genetic cause. A sudden fall from 130 mg/dL to 45 mg/dL without medication suggests acquired illness, major diet change, weight loss, thyroid disease, liver disease, or malabsorption.

Cholesterol-lowering medicines

The most common intentional cause of low LDL is medication. Statins reduce cholesterol production in the liver and increase LDL receptor activity, which pulls LDL particles out of the bloodstream. Ezetimibe reduces cholesterol absorption in the intestine. PCSK9 inhibitors and inclisiran increase LDL receptor recycling or reduce PCSK9 activity, allowing the liver to clear more LDL. Bempedoic acid lowers LDL by acting earlier in the cholesterol synthesis pathway in the liver.

Medication-related low LDL is usually expected when a person is being treated for high cardiovascular risk. The result should still be reviewed if LDL becomes extremely low, if side effects occur, or if the person has a history of hemorrhagic stroke, advanced liver disease, frailty, or complex medication interactions.

Inherited low LDL conditions

Some people inherit genes that keep LDL cholesterol low throughout life. The best-known inherited causes include familial hypobetalipoproteinemia, abetalipoproteinemia, chylomicron retention disease, PCSK9 loss-of-function variants, and ANGPTL3 loss-of-function variants.

Familial hypobetalipoproteinemia often involves variants in the APOB gene. One-copy, or heterozygous, forms may cause LDL-C around 20–50 mg/dL and can be discovered incidentally during routine testing. Many people feel well, but some develop fatty liver or mildly elevated liver enzymes. Two-copy, or biallelic, forms are much more serious and can cause very low or absent LDL, poor fat absorption, diarrhea, growth problems in children, low fat-soluble vitamins, neurologic problems, and eye disease.

PCSK9 loss-of-function variants can produce lifelong low LDL and often appear protective against atherosclerotic cardiovascular disease. Many people with these variants are otherwise healthy. That difference is important: genetically low LDL from PCSK9 is not the same clinical picture as very low LDL from APOB-related fat transport problems.

Hyperthyroidism

An overactive thyroid can lower LDL cholesterol by increasing LDL receptor activity and speeding cholesterol turnover. Clues include weight loss despite normal or increased appetite, heat intolerance, tremor, anxiety, fast heartbeat, frequent bowel movements, sweating, and trouble sleeping. A thyroid-stimulating hormone test, often with free T4, can help confirm or rule out this cause.

Liver disease and severe illness

The liver makes cholesterol, packages lipoproteins, clears LDL particles, and produces many proteins needed for normal metabolism. Chronic liver disease, acute hepatitis, advanced cirrhosis, severe inflammation, infection, and some cancers can lower cholesterol levels. In these situations, low LDL is not protective by itself; it may reflect reduced liver function, poor nutrition, inflammation, or high metabolic stress.

A hepatic function panel can help check ALT, AST, alkaline phosphatase, bilirubin, albumin, and related markers. If LDL is unexpectedly low and liver enzymes are abnormal, the result should be interpreted as part of the broader liver picture rather than as a cholesterol success.

Malabsorption, undernutrition, and rapid weight loss

LDL cholesterol can fall when the body absorbs too little fat or receives too few calories. Possible causes include celiac disease, inflammatory bowel disease, chronic pancreatitis, bile acid problems, bowel surgery, eating disorders, severe dietary restriction, and long periods of poor intake. Symptoms may include chronic diarrhea, greasy or floating stools, bloating, weight loss, bruising, dry eyes, night blindness, bone pain, neuropathy, or muscle weakness.

Very low LDL together with low triglycerides and low fat-soluble vitamins raises more concern for poor fat absorption or inherited fat transport disorders. Vitamin A, D, E, and K status may need testing when symptoms or very low lipid levels point in that direction.

Chronic inflammation, infection, and malignancy

Long-term inflammation can reduce cholesterol levels, especially during active disease. Chronic infections, autoimmune disease, some cancers, and severe inflammatory states may lower LDL and total cholesterol. A low LDL result in this setting does not mean the arteries are risk-free. It may be a marker of ongoing illness.

A complete blood count, inflammatory markers, liver and kidney tests, and symptom-based evaluation can help. A complete blood count may show anemia, abnormal white blood cell patterns, or platelet changes that support a wider evaluation.

Very Low LDL From Cholesterol-Lowering Treatment

Very low LDL is often intentional in people with established atherosclerotic cardiovascular disease. This includes people who have had a heart attack, ischemic stroke, transient ischemic attack from artery disease, coronary stent, bypass surgery, peripheral artery disease, or significant coronary calcium. In these groups, lowering LDL reduces the chance of future cardiovascular events.

Modern lipid treatment has moved beyond simply “normal” versus “abnormal.” A person with no known artery disease may have a different LDL target than someone who has already had a heart attack. For high-risk and very-high-risk patients, clinicians often use targets such as below 70 mg/dL or below 55 mg/dL, depending on the guideline, risk level, and history.

This means an LDL-C of 48 mg/dL may be excellent after a heart attack but unusual in an untreated person with weight loss and diarrhea. The same number has different meaning because the medical situation is different.

Does treatment-related very low LDL need to be raised?

Treatment-related very low LDL usually does not need to be raised just because it is low. If a person is tolerating therapy and has high cardiovascular risk, clinicians often continue treatment because lower LDL exposure is linked with fewer plaque-related events.

The discussion changes when LDL is extremely low and the patient has other risk factors for harm, such as previous brain bleeding, uncontrolled high blood pressure, advanced frailty, major liver disease, or symptoms that began after medication changes. In those cases, the clinician may review the dose, treatment combination, risk history, and whether the measured LDL is accurate.

Medication should not be stopped only because the lab report flags LDL as low. Stopping therapy after a heart attack or stent can raise risk if it leads to LDL rebound. Dose changes should be individualized.

Statins, PCSK9 inhibitors, and safety concerns

People often worry that very low LDL will prevent the body from making hormones, vitamin D, bile acids, or cell membranes. In most treated adults, this is not what happens. The body makes cholesterol inside cells, and blood LDL-C is not the same as total body cholesterol supply. LDL-lowering drugs reduce circulating LDL particles; they do not remove all cholesterol from tissues.

Statins can cause muscle symptoms in some people and slightly raise diabetes risk in susceptible individuals, but these effects are not simply caused by the LDL number being low. PCSK9 inhibitors can lower LDL to very low levels, and clinical evidence has generally been reassuring for major safety outcomes. Mild injection-site reactions can occur with injectable therapies.

If symptoms appear after starting or increasing treatment, the timing matters. Muscle pain, weakness, dark urine, severe fatigue, memory concerns, new diabetes-range glucose, liver enzyme changes, or allergic symptoms should be discussed with a clinician. The answer may be dose adjustment, checking creatine kinase or liver enzymes, switching medication, or confirming that the symptom has another cause.

Health Effects and Symptoms Linked With Very Low LDL

Most people with low LDL have no symptoms from the LDL number itself. Symptoms, when present, usually come from the cause of the low LDL rather than from LDL being low in isolation. For example, diarrhea and weight loss may come from malabsorption; tremor and palpitations may come from hyperthyroidism; jaundice may come from liver disease; neurologic symptoms may come from severe vitamin E deficiency in rare genetic disorders.

Possible symptoms that deserve attention

Low LDL should be reviewed more carefully when it occurs with:

• Unintentional weight loss, poor appetite, night sweats, or persistent fatigue
• Chronic diarrhea, greasy stools, floating stools, bloating, or abdominal pain
• Tremor, fast heartbeat, heat intolerance, anxiety, or unexplained sweating
• Yellow skin or eyes, dark urine, pale stools, easy bruising, or swelling in the abdomen
• Numbness, tingling, poor balance, muscle weakness, vision changes, or night blindness
• Repeated LDL-C below about 50 mg/dL without cholesterol-lowering medication
• Low LDL plus very low total cholesterol, very low triglycerides, or low ApoB
• Children with poor growth, chronic diarrhea, neurologic signs, or very low cholesterol

These patterns do not prove a serious condition, but they make the result more than a simple cholesterol number.

Fat-soluble vitamin deficiency

The strongest nutrient concerns occur in rare inherited disorders that impair ApoB-containing lipoproteins, especially severe APOB-related familial hypobetalipoproteinemia and abetalipoproteinemia. These conditions can limit transport and absorption of fat and fat-soluble vitamins.

Vitamin E deficiency can affect nerves and muscles, causing poor coordination, reduced reflexes, neuropathy, and weakness. Vitamin A deficiency can cause night blindness and eye problems. Vitamin D deficiency can contribute to bone pain, low bone density, and muscle symptoms. Vitamin K deficiency can lead to easy bruising or abnormal bleeding because vitamin K is needed for normal clotting.

This is different from a person whose LDL is low because a statin and PCSK9 inhibitor are working well. In treatment-related low LDL, fat absorption is usually normal unless another digestive condition is present.

Liver fat and low LDL

Some inherited low-LDL conditions can increase fat buildup in the liver even though LDL in the blood is low. This can feel confusing because high cholesterol is often linked with fatty liver in everyday discussion. In APOB-related familial hypobetalipoproteinemia, the liver may have trouble exporting fat properly, so fat can collect in liver cells.

Clues include mildly high ALT or AST, imaging that shows fatty liver, very low LDL-C, low ApoB, and family members with similar lipid patterns. Follow-up may include liver enzyme monitoring, ultrasound or other imaging, fat-soluble vitamin testing, and sometimes genetic evaluation.

Hemorrhagic stroke concerns

Very low LDL has been studied in relation to hemorrhagic stroke, which is bleeding into or around the brain. Some observational studies have found an association between very low cholesterol and higher bleeding stroke risk. Some analyses of lipid-lowering trials suggest a small increase in hemorrhagic stroke events with certain intensive lipid-lowering strategies, while the overall reduction in ischemic heart attacks and ischemic strokes usually outweighs that concern for high-risk cardiovascular patients.

The risk is not the same for everyone. A person with uncontrolled hypertension, previous intracerebral hemorrhage, heavy alcohol use, cerebral amyloid angiopathy, or other bleeding-prone brain conditions needs a more individualized discussion. Blood pressure control is especially important because high blood pressure is a major driver of brain bleeding.

Mood, cognition, hormones, and cancer

Low cholesterol has been linked in some older observational studies with depression, cancer, infections, or frailty. These findings are difficult to interpret because illness itself can lower cholesterol. In other words, low LDL may sometimes be a result of disease rather than a cause.

For cognition, large LDL-lowering trials have not shown a clear pattern of major cognitive harm from achieving low LDL with modern treatment. For hormones, most adults with low LDL from treatment still make steroid hormones because cells synthesize cholesterol internally. For cancer, a new drop in cholesterol can sometimes appear in people with chronic illness or malignancy, but low LDL treatment has not been shown to cause cancer in the way many people fear.

The safest interpretation is context-based: expected low LDL during cardiovascular prevention is usually reassuring, while unexplained falling cholesterol with systemic symptoms deserves evaluation.

What to Do After a Low LDL Result

A low LDL result should be handled in a stepwise way. The first step is to decide whether the result was expected. If the person recently started a statin, ezetimibe, PCSK9 inhibitor, inclisiran, bempedoic acid, major weight-loss plan, or a very low-fat diet, the cause may be clear. If the result is surprising, repeat testing and a broader health review are reasonable.

Step 1: Confirm the result

Repeat the lipid panel, ideally under stable conditions. Use the same fasting status each time when possible. Tell the clinician about recent illness, weight loss, diet changes, alcohol intake, pregnancy status, supplements, and medication changes.

If triglycerides were high or the calculated LDL seems inconsistent with the rest of the panel, ask whether direct LDL-C, non-HDL cholesterol, ApoB, or an advanced lipid panel would clarify the result.

Step 2: Review the full lipid pattern

LDL should not be read alone. Total cholesterol, HDL, triglycerides, non-HDL cholesterol, and ApoB help show whether low LDL is isolated or part of a wider low-lipid pattern.

Low LDL plus normal triglycerides in a person on treatment is often expected. Low LDL plus very low triglycerides can point toward genetics, low intake, or malabsorption. Low LDL plus high triglycerides can mean the calculated LDL is misleading. Low LDL plus high ApoB can mean many cholesterol-poor particles are present even though LDL-C looks low.

If total cholesterol is also low, the related topic of low total cholesterol may help frame the broader pattern.

Step 3: Look for acquired causes

A clinician may consider tests such as:

• Thyroid-stimulating hormone and free T4 for hyperthyroidism
• Liver enzymes, bilirubin, albumin, and clotting tests when liver disease is possible
• A comprehensive metabolic panel to review liver, kidney, protein, glucose, and electrolyte patterns
• Complete blood count to look for anemia, infection clues, or blood cell abnormalities
• Inflammatory markers when chronic inflammatory disease is suspected
• Celiac testing, stool fat evaluation, pancreatic tests, or gastroenterology referral when malabsorption symptoms are present
• Hepatitis, HIV, or other infection testing when symptoms or risk factors fit
• Age-appropriate cancer screening when weight loss, anemia, bleeding, or systemic symptoms raise concern

The testing should match the person’s symptoms and history. Low LDL alone does not justify every possible test.

Step 4: Consider genetics when LDL is persistently very low

Genetic causes become more likely when LDL-C is repeatedly below about 50 mg/dL without medication, especially if ApoB is also low or family members have similar results. Genetics are also more likely when very low LDL appears with fatty liver, low triglycerides, neurologic symptoms, fat-soluble vitamin deficiency, or childhood growth and digestive problems.

Testing may include ApoB, fat-soluble vitamins, INR, liver imaging, family lipid testing, and genetic counseling or genetic testing. Children with extremely low cholesterol, chronic diarrhea, poor growth, or neurologic signs should be evaluated promptly because early vitamin replacement can prevent serious complications in some inherited disorders.

Step 5: Do not self-treat by raising LDL

Trying to raise LDL by eating more saturated fat, stopping prescribed medication, or adding high-cholesterol foods is usually not the right response. If LDL is low because of treatment, raising it may increase cardiovascular risk. If LDL is low because of illness or malabsorption, the correct response is to diagnose and treat the cause, not simply chase a higher LDL number.

Nutrition changes should match the reason. A person with malabsorption may need targeted digestive evaluation and vitamin replacement. A person with overly restrictive dieting may need adequate calories, protein, essential fats, and medical support. A person with high cardiovascular risk may need to continue LDL-lowering therapy while monitoring for side effects.

How Low LDL Fits Into Heart Risk

Low LDL usually lowers atherosclerotic risk, but it does not describe the whole cardiovascular picture. Plaque risk depends on many factors: blood pressure, smoking, diabetes, kidney function, inflammation, age, family history, Lp(a), ApoB, triglyceride-rich remnants, body weight, sleep, physical activity, and previous cardiovascular events.

A person with LDL-C of 45 mg/dL after intensive therapy may still need blood pressure control, diabetes management, smoking cessation, exercise, and antiplatelet therapy if prescribed. A person with LDL-C of 60 mg/dL but very high Lp(a) may still have inherited risk. A person with LDL-C of 70 mg/dL and high triglycerides may still have remnant cholesterol and insulin resistance concerns.

For people with a history of high LDL, the related issue of high LDL cholesterol is cumulative exposure. Years of high LDL earlier in life can leave plaque behind even after LDL is lowered. Lowering LDL reduces future risk, but it does not instantly erase existing plaque.

Advanced markers can help when standard LDL-C does not match the person’s risk. LDL particle number, ApoB, non-HDL cholesterol, Lp(a), and inflammatory markers may refine risk in selected cases. For example, LDL particle number can show whether many LDL particles remain despite a modest LDL-C value.

Low LDL should be seen as one part of a larger risk map. When low LDL is expected and treatment-related, it often signals effective risk reduction. When it is unexplained, it may signal an underlying condition. When it is paired with other risk markers, the full pattern matters more than the LDL number alone.

References

• 2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias 2025 (Guideline)
• Guidelines for the Management of Dyslipidemia 2025 (Guideline)
• Monogenic Disorders Causing Hypobetalipoproteinemia 2024 (Review)
• APOB-Related Familial Hypobetalipoproteinemia 2021 (Review)
• Lipid-Lowering Therapy and Risk of Hemorrhagic Stroke: A Systematic Review and Meta-Analysis of Randomized Controlled Trials 2024 (Systematic Review)
• Safety and Efficacy of Achieving Very Low LDL Cholesterol Concentrations with PCSK9 Inhibitors 2025 (Systematic Review)

Disclaimer

A low LDL cholesterol result should be interpreted with your medical history, medication list, cardiovascular risk, and the rest of your lipid panel. Do not stop prescribed cholesterol-lowering medication or try to raise LDL cholesterol without medical advice, especially if you have heart disease, stroke history, diabetes, kidney disease, or a stent. Seek urgent care for stroke symptoms, chest pain, severe weakness, fainting, black stools, vomiting blood, jaundice with confusion, or sudden neurologic changes.